Ian Dunn to Adult
This is a "connection" page, showing publications Ian Dunn has written about Adult.
Connection Strength
1.753
-
An institutional experience in applying quality improvement measures to pituitary surgery: clinical and resource implications. Neurosurg Focus. 2023 Dec; 55(6):E10.
Score: 0.096
-
The prognostic significance of HIST1H3B/C and H3F3A K27M mutations in diffuse midline gliomas is influenced by patient age. J Neurooncol. 2022 Jul; 158(3):405-412.
Score: 0.086
-
Absence of Survival Improvement for Patients with Esthesioneuroblastoma Over the Past 2 Decades: A Population-Based Study. World Neurosurg. 2022 01; 157:e245-e253.
Score: 0.083
-
Adverse Events After Microvascular Decompression: A National Surgical Quality Improvement Program Analysis. World Neurosurg. 2019 Aug; 128:e884-e894.
Score: 0.070
-
Clinical applications of dynamic CT angiography for intracranial lesions. Acta Neurochir (Wien). 2018 04; 160(4):675-680.
Score: 0.064
-
Unplanned Reoperation After Craniotomy for Tumor: A National Surgical Quality Improvement Program Analysis. Neurosurgery. 2017 Nov 01; 81(5):761-771.
Score: 0.063
-
Prosthetic Replacement of the Ocular Surface Ecosystem Treatment of Ocular Surface Disease After Skull Base Tumor Resection. World Neurosurg. 2018 Feb; 110:e124-e128.
Score: 0.063
-
Readmission After Craniotomy for Tumor: A National Surgical Quality Improvement Program Analysis. Neurosurgery. 2017 04 01; 80(4):551-562.
Score: 0.060
-
Landscape of Genomic Alterations in Pituitary Adenomas. Clin Cancer Res. 2017 Apr 01; 23(7):1841-1851.
Score: 0.058
-
Time Course of Symptomatic Recovery After Endoscopic Transsphenoidal Surgery for Pituitary Adenoma Apoplexy in the Modern Era. World Neurosurg. 2016 Dec; 96:434-439.
Score: 0.058
-
Body habitus, serum albumin, and the outcomes after craniotomy for tumor: a National Surgical Quality Improvement Program analysis. J Neurosurg. 2017 Mar; 126(3):677-689.
Score: 0.057
-
Thrombocytopenia and craniotomy for tumor: A National Surgical Quality Improvement Program analysis. Cancer. 2016 Jun 01; 122(11):1708-17.
Score: 0.056
-
Length of hospital stay after craniotomy for tumor: a National Surgical Quality Improvement Program analysis. Neurosurg Focus. 2015 Dec; 39(6):E12.
Score: 0.055
-
Integrated Genomic Characterization of a Pineal Parenchymal Tumor of Intermediate Differentiation. World Neurosurg. 2016 Jan; 85:96-105.
Score: 0.054
-
Utility of dynamic computed tomography angiography in the preoperative evaluation of skull base tumors. J Neurosurg. 2015 Jul; 123(1):1-8.
Score: 0.053
-
"Extraoperative" MRI (eoMRI) for Brain Tumor Surgery: Initial Results at a Single Institution. World Neurosurg. 2015 Jun; 83(6):921-8.
Score: 0.052
-
Isolated cerebral mucormycosis of the basal ganglia. Clin Neurol Neurosurg. 2014 Sep; 124:102-5.
Score: 0.050
-
A molecularly integrated grade for meningioma. Neuro Oncol. 2022 05 04; 24(5):796-808.
Score: 0.021
-
Early Detection and Management of Venous Thrombosis in Skull Base Surgery: Role of Routine Doppler Ultrasound Monitoring. Neurosurgery. 2022 07 01; 91(1):115-122.
Score: 0.021
-
Postoperative Day 1 Morning Cortisol Value as a Biomarker to Predict Long-term Remission of Cushing Disease. J Clin Endocrinol Metab. 2021 01 01; 106(1):e94-e102.
Score: 0.020
-
Is Falcine Meningioma a Diffuse Disease of the Falx? Case Series and Analysis of a "Grade Zero" Resection. Neurosurgery. 2020 10 15; 87(5):900-909.
Score: 0.019
-
Targeting PD-L1 Initiates Effective Antitumor Immunity in a Murine Model of Cushing Disease. Clin Cancer Res. 2020 03 01; 26(5):1141-1151.
Score: 0.018
-
Brachytherapy with surgical resection as salvage treatment for recurrent high-grade meningiomas: a matched cohort study. J Neurooncol. 2020 Jan; 146(1):111-120.
Score: 0.018
-
Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022. Clin Breast Cancer. 2020 04; 20(2):145-151.e2.
Score: 0.018
-
Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial. J Clin Oncol. 2019 03 20; 37(9):741-750.
Score: 0.017
-
Efficacy of adjuvant radiotherapy for atypical and anaplastic meningioma. Cancer Med. 2019 01; 8(1):13-20.
Score: 0.017
-
Predicting Readmission and Reoperation for Benign Cranial Nerve Neoplasms: A Nationwide Analysis. World Neurosurg. 2019 Jan; 121:e223-e229.
Score: 0.017
-
Demonstration of Infectious Transgression Through the Skull Base Occurring 9 Years After Pituitary Adenoma Resection. World Neurosurg. 2018 Nov; 119:215-219.
Score: 0.017
-
Radiographic prediction of meningioma grade by semantic and radiomic features. PLoS One. 2017; 12(11):e0187908.
Score: 0.016
-
Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone. J Neurooncol. 2017 Dec; 135(3):581-591.
Score: 0.016
-
Readmission and Other Adverse Events after Transsphenoidal Surgery: Prevalence, Timing, and Predictive Factors. J Am Coll Surg. 2017 May; 224(5):971-979.
Score: 0.015
-
Hybrid Surgery Management of Giant Hypervascular Tumors: Intraoperative Endovascular Embolization with Microsurgical Resection. World Neurosurg. 2017 Jun; 102:157-166.
Score: 0.015
-
Timing of Decompressive Hemicraniectomy for Stroke: A Nationwide Inpatient Sample Analysis. Stroke. 2017 03; 48(3):704-711.
Score: 0.015
-
Functional Gonadotroph Adenomas: Case Series and Report of Literature. Neurosurgery. 2016 Dec; 79(6):823-831.
Score: 0.015
-
Patient Age and the Outcomes after Decompressive Hemicraniectomy for Stroke: A Nationwide Inpatient Sample Analysis. Neurocrit Care. 2016 12; 25(3):371-383.
Score: 0.015
-
Impact of operative length on post-operative complications in meningioma surgery: a NSQIP analysis. J Neurooncol. 2017 01; 131(1):59-67.
Score: 0.015
-
Predictors of aggressive clinical phenotype among immunohistochemically confirmed atypical adenomas. J Clin Neurosci. 2016 Dec; 34:246-251.
Score: 0.015
-
Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Posttreatment Follow-up Evaluation of Patients With Nonfunctioning Pituitary Adenomas. Neurosurgery. 2016 Oct; 79(4):E541-3.
Score: 0.015
-
Updates in the management of brain metastases. Neuro Oncol. 2016 08; 18(8):1043-65.
Score: 0.014
-
Genomic characterization of recurrent high-grade astroblastoma. Cancer Genet. 2016 Jul-Aug; 209(7-8):321-30.
Score: 0.014
-
The utility of high-resolution intraoperative MRI in endoscopic transsphenoidal surgery for pituitary macroadenomas: early experience in the Advanced Multimodality Image Guided Operating suite. Neurosurg Focus. 2016 Mar; 40(3):E18.
Score: 0.014
-
Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma. Neuro Oncol. 2016 05; 18(5):649-55.
Score: 0.014
-
The frequency and severity of intracranial hypotension post-intraoperative lumbar drainage using a Tuohy needle and the traditional needle. Br J Neurosurg. 2016 Aug; 30(4):438-43.
Score: 0.014
-
Reconstruction of Rare Skull Metastases Using Free Latissimus Dorsi Flap and the Role of Preoperative Embolization in Hypervascular Skull Tumors. J Craniofac Surg. 2015 Nov; 26(8):2289-92.
Score: 0.014
-
Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy. J Natl Cancer Inst. 2016 Feb; 108(2).
Score: 0.014
-
Intrasellar abscess following pituitary surgery. Pituitary. 2015 Oct; 18(5):731-7.
Score: 0.014
-
Extent of resection and overall survival for patients with atypical and malignant meningioma. Cancer. 2015 Dec 15; 121(24):4376-81.
Score: 0.013
-
Salvage whole brain radiotherapy or stereotactic radiosurgery after initial stereotactic radiosurgery for 1-4 brain metastases. J Neurooncol. 2015 Sep; 124(3):429-37.
Score: 0.013
-
Incidence, risk factors, and reasons for hospitalization among glioblastoma patients receiving chemoradiation. J Neurooncol. 2015 Aug; 124(1):137-46.
Score: 0.013
-
The combined microscopic-endoscopic technique for radical resection of cerebellopontine angle tumors. J Neurosurg. 2015 Nov; 123(5):1301-11.
Score: 0.013
-
Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma. Neuro Oncol. 2015 Oct; 17(10):1344-55.
Score: 0.013
-
Incidence, risk factors and management of severe post-transsphenoidal epistaxis. J Clin Neurosci. 2015 Jan; 22(1):116-22.
Score: 0.013
-
Local control after fractionated stereotactic radiation therapy for brain metastases. J Neurooncol. 2014 Nov; 120(2):339-46.
Score: 0.013
-
Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma. Neuro Oncol. 2014 Nov; 16(11):1547-53.
Score: 0.012
-
True petroclival meningiomas: results of surgical management. J Neurosurg. 2014 Jan; 120(1):40-51.
Score: 0.012
-
Craniectomy-associated Progressive Extra-Axial Collections with Treated Hydrocephalus (CAPECTH): redefining a common complication of decompressive craniectomy. J Clin Neurosci. 2012 Sep; 19(9):1222-7.
Score: 0.011
-
Resolution of extra-axial collections after decompressive craniectomy for ischemic stroke. J Clin Neurosci. 2012 Feb; 19(2):231-4.
Score: 0.010
-
Benefit of ventriculoperitoneal cerebrospinal fluid shunting and intrathecal chemotherapy in neoplastic meningitis: a retrospective, case-controlled study. J Neurosurg. 2011 Oct; 115(4):730-6.
Score: 0.010
-
Meningiomas involving the optic canal: pattern of involvement and implications for surgical technique. Neurosurg Focus. 2011 May; 30(5):E12.
Score: 0.010
-
The neurosurgical anatomy of the sphenoid sinus and sellar floor in endoscopic transsphenoidal surgery. J Neurosurg. 2011 May; 114(5):1319-30.
Score: 0.010
-
Intracerebral hemorrhage secondary to thrombocytopenia in a patient treated with temozolomide. Clin Neurol Neurosurg. 2010 Oct; 112(8):741-2.
Score: 0.010
-
Genomics of human glioblastoma multiforme: a glimpse of the future. Neurosurgery. 2008 Dec; 63(6):15.
Score: 0.008
-
Lumbar epidural hematoma associated with spondylolyses. J Neurosurg Spine. 2008 Feb; 8(2):174-80.
Score: 0.008
-
HER2/neu gene amplification and protein overexpression in G3 pT2 transitional cell carcinoma of the bladder: a role for anti-HER2 therapy? Eur J Cancer. 2004 Jan; 40(1):56-63.
Score: 0.006
-
HER2/neu overexpression in the development of muscle-invasive transitional cell carcinoma of the bladder. Br J Cancer. 2003 Oct 06; 89(7):1305-9.
Score: 0.006
-
Genetic aberrations of c-myc and CCND1 in the development of invasive bladder cancer. Br J Cancer. 2002 Sep 09; 87(6):654-8.
Score: 0.005
-
Endoscopic findings in chronic hemodialysis patients with upper gastrointestinal bleeding. Am J Gastroenterol. 1983 Nov; 78(11):720-1.
Score: 0.001
-
Prosthetic arteriovenous fistula for vascular access in hemodialysis. Am J Surg. 1976 Sep; 132(3):368-72.
Score: 0.001